Medicine and Dentistry
Yttrium 90
100%
Radioembolization
91%
Neoplasm
88%
Hepatocellular Carcinoma
77%
Microsphere
61%
Transcatheter Arterial Chemoembolization
47%
Liver Tumor
41%
Liver Metastasis
27%
Perfusion Weighted Imaging
24%
Diseases
18%
Magnetic Resonance Imaging
18%
Radiofrequency Ablation
16%
Overall Survival
16%
Oncology
14%
Cancer
13%
Arterial Embolization
12%
Metastatic Carcinoma
12%
Bilirubin
12%
Necrosis
12%
Response Evaluation Criteria in Solid Tumors
11%
Embolization
11%
Liver Cancer
10%
Segmentectomy
10%
Malignant Neoplasm
9%
Portal Vein Thrombosis
9%
Diffusion MRI
9%
Radiation Therapy
8%
Hazard Ratio
8%
Computer Assisted Tomography
8%
Interventional Radiology
8%
Adverse Event
7%
Multivariate Analysis
7%
Common Hepatic Artery
7%
Cholangiocarcinoma
7%
Surgery
7%
Interventional Radiologist
6%
Chemotherapy
6%
Portal Hypertension
6%
Oncologist
5%
Cryoablation
5%
Recurrent Disease
5%
Liver Toxicity
5%
Lobectomy
5%
Uterine Artery Embolization
5%
Hypoxia Inducible Factor 1
5%
Hepatic Portal Vein
5%
Recanalization
5%
Keyphrases
Hepatocellular Carcinoma
75%
Radioembolization
63%
Yttrium-90 Microspheres
44%
Yttrium-90 Radioembolization
42%
Chemoembolization
40%
Tumor
32%
Intra-arterial
31%
Yttrium-90
28%
Liver Tumor
26%
Transcatheter
25%
VX2 Tumor
21%
Time to Progression
19%
Perfusion Magnetic Resonance Imaging
18%
Tumor Response
18%
Radiofrequency Ablation
17%
Confidence Interval
16%
European Association for the Study of the Liver
16%
Transcatheter Arterial Chemoembolization
14%
Liver Metastasis
14%
World Health Organization
13%
Radiation Segmentectomy
12%
Overall Survival
12%
Necrosis
12%
Liver
11%
Imaging Response
11%
Magnetic Resonance Imaging
11%
Perfusion
10%
Locoregional Therapy
10%
Intra-procedural
10%
Transcatheter Arterial Embolization
10%
Radiologic-pathologic Correlation
10%
Response Evaluation Criteria in Solid Tumors (RECIST)
10%
Portal Vein Thrombosis
9%
Tumor Perfusion
9%
Transarterial Chemoembolization
9%
Liver Malignancy
9%
Embolization
9%
Response Rate
9%
Median Survival
8%
Lobar
8%
Tumor Size
8%
Hazard Ratio
8%
Clinical Toxicity
8%
Interventional Radiology
8%
Radiological Response
8%
Patient Cohort
8%
Patient Survival
8%
Partial Response
7%
Interventional Radiologist
7%
Multivariate Analysis
7%